Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees

Feyt

Luc Feyt, Mont-Saint-Guibert BE

Patent application number	Description	Published
20110086791	SURFACE TREATMENT COMPOSITION CONTAINING PHOSPHONIC ACID COMPOUNDS - Surface treatment compositions containing selected phosphonic acid compounds are disclosed. The compositions contain major levels of surface-active agents in combination with additive levels of the phosphonic acid compounds, and, in accordance with needs and objectives, conventional optional ingredients and additive agents. The inventive compositions can provide significant performance benefits, among others novel synergies and eminently desirable regulatory and environmental acceptability.	04-14-2011

Nathalie Feyt, Cuges Les Pins FR

Patent application number	Description	Published
20090254777	Detector of Abnormal Destruction of Memory Sectors - The invention relates to an integrated circuit comprising at least one microprocessor [	10-08-2009

Rolando Pajon Feyt, La Habana CU

Patent application number	Description	Published
20090208521	PHARMACEUTICAL COMPOSITIONS CONTAINING PROTEIN NMA0939 - The present invention is related to field of medicine, particularly to the development of pharmaceutical formulations containing NMA0939 protein. Formulations described in this invention are able to confer protection against different diseases caused or not by pathogenic agents. NMA0939 protein was identified as a	08-20-2009
20090297547	PHARMACEUTICAL COMPOSITION CONTAINING THE NMB0938 PROTEIN - The present invention is related to field of medicine, particularly to the development of pharmaceutical formulation containing NMB0938 protein. Formulation described in this invention is able to confer protection against different diseases caused or not by pathogenic agents. NMB0938 protein was identified as a	12-03-2009
20100129387	PHARMACEUTICAL COMPOSITION CONTAINING THE NMB0606 PROTEIN - The present invention is related to field of medicine, particularly to the development of pharmaceutical formulation containing NMB0606 protein. Formulation described in this invention is able to confer protection against different diseases caused or not by pathogenic agents. NMB0606 protein was identified as a	05-27-2010
20100172931	Pharmaceutical Composition Containing the NMB1796 Protein - The present invention is related to field of medicine, particularly to the development of pharmaceutical composition containing the NMB1796 protein. The composition described in this invention are able to confer protection against different diseases caused or not by pathogenic agents. The NMB1796 protein was identified as a	07-08-2010